Source: Neoplasia (New York, N.Y.)Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 5, Pp 515-528 (2021)Digital.CSIC. Repositorio Institucional del CSICinstname

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Phase II trial of single‐agent panobinostat consolidation improves responses after sub‐optimal transplant outcomes in multiple myeloma

Authors : Anna Kalff; Geoffrey R. Hill; Malarmathy Ramachandran

Subjects: Adult; Male; Oncology

Source: British Journal of Haematology

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation

Authors : Johan Maertens; Annoek E.C. Broers; Yvette van Norden ...

Subjects: Adult; Oncology; MAINTENANCE THERAPY

Source: BLOOD ADVANCES, 4(18), 4430-4437. American Society of HematologyBlood advances, 4(18), 4430-4437. American Society of HematologyKalin, B, van Norden, Y, van Gelder, M, Breems, D, Maertens,

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

High-dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a nonhuman primate model

Authors : Afroz S. Mohammad; Christopher F. Janssen; Natasha Kharas

Subjects: Medulloblastoma; Chemotherapy; Catheter insertion

Source: J Neurosurg Pediatr

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance

Authors : Kelsey C. Bertrand; Ansuman Chattopadhyay; Max I. Myers

Subjects: 0301 basic medicine; Cancer Research; medicine.drug_class

Source: Molecular Cancer Research. 18:1004-1017

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies

Authors : Jessica A. Pollard; Victor M. Aquino; Leigh Marcus

Subjects: Adult; Male; Oncology

Source: Pediatric Hematology and Oncology. 37:465-474

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines

Authors : Nair Lopes; Rui Henrique; Margareta P Correia

Subjects: 0301 basic medicine; panobinostat; Stromal cell

Source: PharmaceuticalsPharmaceuticals, Vol 14, Iss 670, p 670 (2021)Volume 14Issue 7

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Efficacy of Panobinostat for the Treatment of Multiple Myeloma

Authors : Nikolaos Kanellias; Evangelos Terpos; Efstathios Kastritis

Subjects: 0301 basic medicine; Oncology; Drug

Source: Journal of OncologyJournal of Oncology, Vol 2020 (2020)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention

Design and synthesis of diazine-based panobinostat analogues for HDAC8 inhibition

Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair

Phase II trial of single‐agent panobinostat consolidation improves responses after sub‐optimal transplant outcomes in multiple myeloma

Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation

High-dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a nonhuman primate model

Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance

A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies

Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines

Efficacy of Panobinostat for the Treatment of Multiple Myeloma

اتصل بنا

اتبع